January 9, 2025 - 17:10

In a significant move to enhance its portfolio, Synaffix, a leader in antibody-drug conjugate (ADC) technology, has entered into a new licensing agreement with Boehringer Ingelheim. This partnership allows Boehringer to leverage Synaffix's advanced ADC technologies for a specified number of cancer targets, although the exact details regarding the number of targets remain confidential.
This agreement marks a strategic step for Synaffix as it continues to build on its momentum from last year, when it secured several partnerships. Additionally, Synaffix has expanded its collaboration network by forming a technology licensing deal with Mitsubishi Tanabe Pharma in Japan. These developments underscore Synaffix's commitment to advancing cancer treatment options through innovative ADC technologies.
As the landscape of cancer therapeutics evolves, this collaboration with Boehringer Ingelheim is poised to accelerate the development of novel ADC therapies, potentially leading to more effective treatment solutions for patients battling cancer.
August 19, 2026 - 04:25
Integrating Technology in the Classroom Must Be Handled With Caution and PragmatismSchool systems across the country are moving forward with digital learning tools, but the push to modernize classrooms is meeting a wave of caution from educators and administrators. At the 2026...
August 18, 2026 - 09:22
OMSI hosts Portland Festival of Cinema, Animation & Technology this weekA week-long showcase of independent filmmaking and digital innovation kicks off this summer at the Oregon Museum of Science and Industry. The Portland Festival of Cinema, Animation and Technology...
August 17, 2026 - 17:39
CACI Selected to Strengthen and Modernize Technology Architectures for U.S. Space Force GuardiansRESTON, Va., August 17, 2026 - CACI International has secured a new contract with the U.S. Space Force to deliver technology upgrades aimed at defending national interests against emerging...
August 17, 2026 - 00:03
The next evolution of technology transferToday`s scientific breakthroughs rarely emerge in isolation. They are increasingly shaped by collaboration across disciplines, institutions, and sectors. But the path from a lab discovery to a...